🇺🇸 FDA
Patent

US 11801268

Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles

granted A61KA61K35/12A61K35/34

Quick answer

US patent 11801268 (Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles) held by Capricor, Inc. expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor, Inc.
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/12, A61K35/34, A61K35/65, A61K9/0014